Aclaris Therapeutics (ACRS) Earnings
|
Expand Research on ACRS
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +13.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.28 | N/A | N/A | $2.05M | N/A | N/A | N/A | ||
| 2/22/24 | Q423 | N/A | -$0.35 | N/A | N/A | $4.66M | N/A | N/A | N/A | ||
| 2/26/24 | Q423 | N/A | -$0.35 | N/A | N/A | $4.66M | N/A | N/A | N/A | ||
11/6/23  |
Q323 | -$0.41 | -$0.48 | +$0.07 | $9.28M | $1.57M | N/A |  | | Details | |
| 11/7/23 | Q323 | N/A | -$0.48 | N/A | N/A | $1.57M | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | -$0.42 | -$0.45 | +$0.03 | $1.87M | $1.9M | N/A | | | Details | |
| 8/3/23 | Q223 | N/A | -$0.45 | N/A | N/A | $1.9M | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.44 | N/A | N/A | $1.75M | N/A | N/A | N/A |
